Search Options Stock News and Analysis from Schaeffer's

Bausch Health Stock Hits 27-Year Low on Patent Decision

https://www.schaeffersresearch.com/content/analysis/2022/07/28/bausch-health-stock-hits-27-year-low-on-patent-decision

7/28/2022 2:51 PM

The shares of Bausch Health Companies Inc (NYSE:BHC) are cratering today, last seen down 50.3% at a roughly 27-year low of $4.32. Today's negative price action came after Delaware federal district c...

Pharmaceutical Stock Moves Higher on Board Changes

https://www.schaeffersresearch.com/content/news/2022/06/24/pharmaceutical-stock-moves-higher-on-board-changes

6/24/2022 9:22 AM

The shares of Bausch Health Companies Inc (NYSE:BHC) are up 4.5% to trade at $7.55 ahead of the open, following changes to its board of directors. Specifically, Chairman Joseph Papa has stepped down...

Bausch Health Spinoff Sends Stock Higher

https://www.schaeffersresearch.com/content/news/2022/01/14/bausch-health-spinoff-sends-stock-higher

1/14/2022 10:14 AM

Bausch Health Companies Inc (NYSE:BHC) just said that its eye-care products unit Bausch + Lomb filed to go public on Thursday on both U.S. and Canadian exchanges via an initial public offering (IPO)....

Pharma Stock Eyes 10th Straight on Shareholder Updates

https://www.schaeffersresearch.com/content/news/2021/02/12/pharma-stock-eyes-10th-straight-on-shareholder-updates

2/12/2021 11:15 AM

The shares of Bausch Health Companies Inc (NYSE:BHC) are up 4.3% at $31.41 at last check, after Icahn Capital LP reported a 7.8% stake in the pharmaceutical concern, which is the equivalent of 27.8 m...

Strong First Week of August Marred by Stimulus, China Tensions

https://www.schaeffersresearch.com/content/news/2020/08/07/strong-first-week-of-august-marred-by-stimulus-china-tensions

8/7/2020 1:28 PM

Volatile sentiment surrounding the stalled second stimulus bill in congress permeated through the market this week, as investors listened for cues as to whether the stiff negotiations would soon be...

PEOPLE ALSO SEARCH FOR